News Room

News & Press Releases

January 9, 2012
Dr. Jill Schwartz discusses the SILCS Diaphragm in Contraceptive Technology Today
November 25, 2011
VOICE Trial Indicates Daily Dosing of Tenofovir Gel Ineffective
October 26, 2011
FACTS 001 Study Announces Enrollment of First Study Participant
October 13, 2011
USAID Awards Cooperative Agreement to CONRAD for Multipurpose Prevention Study
September 28, 2011
CONRAD Statement on VOICE DSMB
September 16, 2011
CONRAD PRESENTS RESULTS OF PIVOTAL CONTRACEPTIVE STUDY AT REPRODUCTIVE HEALTH 2011
July 26, 2011
IAS Rome 2011: CONRAD Teams up with Global Campaign for Microbicides and South Africa's Department of Science and Technology
July 13, 2011
CONRAD Statement on Pre-Exposure Prophylaxis Trials
June 14, 2011
NEXT STEPS FOR TENOFOVIR GEL: CONRAD AND TIA SIGN LICENSE AGREEMENT
June 9, 2011
CAPRISA Leadership Team Wins DST Award
May 13, 2011
HPTN 052 Study Shows 96% Reduction in HIV Transmission
April 22, 2011
Male Hormonal Contraceptive Trial Ending Early
April 18, 2011
CONRAD Commends FHI and FEM-PrEP Study Team
December 20, 2010
CONRAD's Tenofovir Gel Scores Science Magazine's Breakthrough of the Year Top Ten List
November 23, 2010
CONRAD APPLAUDS RESULTS OF GLOBAL iPrEx STUDY
November 2, 2010
USAID AWARDS $5 MILLION TO CONRAD FOR DEVELOPMENT OF A HIGHLY EFFECTIVE CONTRACEPTIVE WITH POTENTIAL TO PREVENT HIV SEXUAL INFECTION
October 25, 2010
FDA and CONRAD Chart U.S. Regulatory Path for 1% Tenofovir Gel for HIV Prevention
July 21, 2010
CAPRISA 004: CONRAD EXECUTIVE DIRECTOR, HENRY GABELNICK, IN THE NEWS
July 20, 2010
CAPRISA 004 FACTSHEETS
July 20, 2010
CAPRISA 004 TOP HEADLINES
July 19, 2010
STUDY OF MICROBICIDE GEL SHOWS REDUCED RISK OF HIV & HERPES INFECTIONS IN WOMEN
July 18, 2010
CAPRISA 004 TRIAL RESULTS PRESENTATION FROM AIDS 2010 CONFERENCE
July 18, 2010
QUESTIONS & ANSWERS: CAPRISA 004 TENOFOVIR GEL TRIAL
May 13, 2010
On the Pill